Advertisement

Killing cancer cells: Get them addicted to drugs

Follow The Hawk on Google News+ Follow

Advertisement


London: Scientists in the UK have found a new way to combat cancer by getting tumour cells addicted to drugs that will kill them in minutes. The technique called "mitopriming" was developed as a research tool while trying to understand how cancer cells die. Mito-priming can be applied to identify new anti-cancer drugs to screen their effectiveness. According to the research paper, BH3-mimetics are a promising new class of cancer drugs developed to specifically kill tumour cells. They target a family of proteins called BCL-2 proteins, which function to keep cancer cells alive. While not yet in use in clinical practice, BH3-mimetic anticancer drugs are showing promise in late-stage clinical trials, particularly in the treatment of chronic lymphocytic leukaemia. Stephen Tait, the lead author of the paper, said, "Mito-priming can be used to rapidly screen for new BH3-mimetics and other anti-cancer drugs, and should improve ways to kill cancer cells. It can also be used to rapidly define the potency and specificity of BH3-mimetics." Finally, the technique will allow us to understand how drug resistance occurs thereby allowing us to prevent this from happening in the first place, he added. "There is currently a lot of interest in targeting BCL2 proteins in the fight against cancer and there will be new therapies emerging in the future," Tait said. The scientists developed mito-priming by producing equal amounts of toxic and protective BCL-2 proteins in cells. "Cells in this state are very sensitive to inhibition of protective BCL-2 function by BH3-mimetics, such that they die within a few minutes of drug addiction," Tait said.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST